Clinical applications of reporter gene technology

Molecular Imaging with Reporter Genes

Volumn , Issue , 2010, Pages 297-314

  Peñuelas, Iván ^a   Yaghoubi, Shahriar S ^b   Prósper, Felipe ^c   Gambhir, Sanjiv Sam ^d  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NAVARRA   (Spain)

^d STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; GENE THERAPY; MEDICINE; MOLECULAR BIOLOGY; MOLECULAR IMAGING; PATIENT TREATMENT;

CLINICAL APPLICATION; GENE EXPRESSION PATTERNS; MOLECULAR MEDICINE; MOLECULAR SIGNATURES; MULTI-MODALITY IMAGING; NON-INVASIVE IMAGING METHODS; NON-INVASIVE TECHNOLOGY; WHOLE-BODY IMAGING;

GENE EXPRESSION;

EID: 84932134854     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511730405.014     Document Type: Chapter

References (61)

1. Hoffman, J.M., Gambhir, S. S. (2007).Molecular imaging: the vision and opportunity for radiology in the future. Radiology 244(1): 39–47.
2. Massoud, T. F., Gambhir, S. S. (2003). Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17(5): 545–580.
3. Massoud, T. F., Gambhir, S. S. (2007). Integrating noninvasive molecular imaging into molecular medicine: an evolving paradigm. Trends Mol Med 13(5): 183–191.
4. Penuelas, I., Boan, J., Marti-Climent, J. M., Sangro, B., Mazzolini, G., Prieto, J. et al. (2004). Positron emission tomography and gene therapy: basic concepts and experimental approaches for in vivo gene expression imaging. Mol Imaging Biol 6(4): 225–238.
5. Yaghoubi, S. S., Wu, L., Liang, Q., Toyokuni, T., Barrio, J. R., Namavari, M. et al. (2001).Direct correlation between positron emission tomographic images of two reporter genes delivered by two distinct adenoviral vectors. Gene Ther 8(14): 1072–1080.
6. Ray, P., Bauer, E., Iyer, M., Barrio, J. R., Satyamurthy, N., Phelps, M. E. et al. (2001). Monitoring gene therapy with reporter gene imaging. Semin Nucl Med 31(4): 312–320.
7. Ray, P., Tsien, R., Gambhir, S. S. (2007). Construction and validation of improved triple fusion reporter gene vectors for molecular imaging of living subjects. Cancer Res 67(7): 3085–3093.
8. Deroose, C.M., De, A., Loening, A.M., Chow, P. L., Ray, P., Chatziioannou, A. F. et al. (2007). Multimodality imaging of tumor xenografts and metastases in mice with combined small-animal PET, small-animal CT, and bioluminescence imaging. J Nucl Med 48(2): 295–303.
9. Ponomarev, V., Doubrovin, M., Serganova, I., Vider, J., Shavrin, A., Beresten, T. et al. (2004). A novel triplemodality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging. Eur J Nucl Med Mol Imaging 31(5): 740–751.
10. Ray, P., De, A., Min, J. J., Tsien, R. Y., Gambhir, S. S. (2004). Imaging tri-fusionmultimodality reporter gene expression in living subjects. Cancer Res 64(4): 1323–1330.
11. Hielscher, A. H. (2005). Optical tomographic imaging of small animals. Curr Opin Biotechnol 16(1): 79–88.
12. Gibson, A. P., Hebden, J. C., Arridge, S. R. (2005). Recent advances in diffuse optical imaging. Phys Med Biol 50(4): R1–43.
13. Hawrysz, D. J., Sevick-Muraca, E. M. (2000). Developments toward diagnostic breast cancer imaging using nearinfrared optical measurements and fluorescent contrast agents. Neoplasia 2(5): 388–417.
14. Venisnik, K. M., Olafsen, T., Gambhir, S. S., Wu, A. M. (2007). Fusion of Gaussia luciferase to an engineered anticarcinoembryonic antigen (CEA) antibody for in vivo optical imaging. Mol Imaging Biol 9(5): 267–277.
15. Labas, Y. A., Gurskaya, N. G., Yanushevich, Y. G., Fradkov, A. F., Lukyanov, K. A., Lukyanov, S. A. et al. (2002). Diversity and evolution of the green fluorescent protein family. Proc Natl Acad Sci U S A 99(7): 4256–4261.
16. Matz, M. V., Fradkov, A. F., Labas, Y. A., Savitsky, A. P., Zaraisky, A. G., Markelov, M. L. et al. (1999). Fluorescent proteins from nonbioluminescent Anthozoa species. Nat Biotechnol 17(10): 969–973.
17. Weissleder, R., Ntziachristos, V. (2003). Shedding light onto live molecular targets. Nat Med 9(1): 123–128.
18. Ntziachristos, V., Tung, C. H., Bremer, C., Weissleder, R. (2002). Fluorescence molecular tomography resolves protease activity in vivo. Nat Med 8(7): 757–760.
19. Funovics, M. A., Weissleder, R., Mahmood, U. (2004). Catheter-based in vivo imaging of enzymeactivity and gene expression: feasibility study inmice. Radiology 231(3): 659–666.
20. Genove, G., DeMarco, U., Xu, H., Goins, W. F., Ahrens, E. T. (2005). A new transgene reporter for in vivo magnetic resonance imaging. Nat Med 11(4): 450–454.
21. Cohen, B., Dafni, H., Meir, G., Harmelin, A., Neeman, M. (2005). Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia 7(2): 109–117.
22. Gilad, A. A., McMahon, M. T., Walczak, P., Winnard, P. T., Jr., Raman, V., van Laarhoven, H.W. et al. (2007). Artificial reporter gene providing MRI contrast based on proton exchange. Nat Biotechnol 25(2): 217–219.
23. Gilad, A. A., Winnard, P. T., Jr., van Zijl, P. C., Bulte, J. W. (2007). Developing MR reporter genes: promises and pitfalls. NMR Biomed 20(3): 275–290.
24. Beanlands, R., Roberts, R. (2007). Positron molecular imaging, an in vivo glimpse of the genome. J Mol Cell Cardiol 43(1): 11–14.
25. Rome, C., Couillaud, F., Moonen, C. T. (2007). Gene expression and gene therapy imaging. Eur Radiol 17(2): 305–319.
26. Penuelas, I., Haberkorn, U., Yaghoubi, S., Gambhir, S. S. (2005). Gene therapy imaging in patients for oncological applications. Eur J Nucl Med Mol Imaging 32(Suppl 2): S384–403.
27. Penuelas, I., Gambhir, S. S. (2005). Imaging studies for evaluating gene therapy in translational research. Drug Discovery Today: Technologies 2(4): 335–343.
28. Liang, Q., Satyamurthy, N., Barrio, J. R., Toyokuni, T., Phelps, M. P., Gambhir, S. S. et al. (2001). Noninvasive, quantitative imaging in living animals of a mutant dopamine D2 receptor reporter gene in which ligand binding is uncoupled fromsignal transduction. GeneTher 8(19): 1490–1498.
29. MacLaren, D. C., Gambhir, S. S., Satyamurthy, N., Barrio, J. R., Sharfstein, S., Toyokuni, T. et al. (1999). Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther 6(5): 785–791.
30. Zinn, K. R., Chaudhuri, T. R. (2002). The type 2 human somatostatin receptor as a platformfor reporter gene imaging. Eur J Nucl Med Mol Imaging 29(3): 388–399.
31. Chung, J. K. (2002). Sodium iodide symporter: its role in nuclear medicine. J Nucl Med 43(9): 1188–1200.
32. Groot-Wassink, T., Aboagye, E. O., Glaser, M., Lemoine, N. R., Vassaux, G. (2002). Adenovirus biodistribution and noninvasive imaging of gene expression in vivo by positron emission tomography using human sodium/iodide symporter as reporter gene. HumGeneTher 13(14): 1723–1735.
33. Haberkorn, U., Henze, M., Altmann, A., Jiang, S., Morr, I., Mahmut, M. et al. (2001). Transfer of the human NaI symporter gene enhances iodide uptake in hepatoma cells. J Nucl Med 42(2): 317–325.
34. Anton, M., Wagner, B., Haubner, R., Bodenstein, C., Essien, B. E., Bonisch, H. et al. (2004). Use of the norepinephrine transporter as a reporter gene for non-invasive imaging of genetically modified cells. J Gene Med 6(1): 119–126.
35. Ponomarev, V., Doubrovin, M., Shavrin, A., Serganova, I., Beresten, T., Ageyeva, L. et al. (2007). A human-derived reporter gene for noninvasive imaging in humans: mitochondrial thymidine kinase type 2. J Nucl Med 48(5): 819–826.
36. Jacobs, A., Voges, J., Reszka, R., Lercher, M., Gossmann, A., Kracht, L. et al. (2001). Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet 358(9283): 727–729.
37. Dempsey, M. F., Wyper, D., Owens, J., Pimlott, S., Papanastassiou, V., Patterson, J. et al. (2006). Assessment of 123IFIAUimaging of herpes simplex viral gene expression in the treatment of glioma. Nucl Med Commun 27(8): 611–617.
38. Penuelas, I., Mazzolini, G., Boan, J. F., Sangro, B., Marti-Climent, J., Ruiz, M. et al. (2005).Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients. Gastroenterology 128(7): 1787–1795.
39. Jacobs, A. H., Rueger, M. A., Winkeler, A., Li, H., Vollmar, S., Waerzeggers, Y. et al. (2007). Imaging-guided gene therapy of experimental gliomas. Cancer Res 67(4): 1706–1715.
40. Weissleder, R. (2006).Molecular imaging in cancer. Science 312(5777): 1168–1171.
41. Phelps, M. E. (2004). Molecular Imaging and Its Biological Applications. 1st ed. New York: Springer-Verlag.
42. Weber, W. A. (2006). Positron emission tomography as an imaging biomarker. J Clin Oncol 24(20): 3282–3292.
43. Yaghoubi, S. S., Barrio, J. R., Namavari, M., Satyamurthy, N., Phelps, M. E., Herschman, H. R. et al. (2005). Imaging progress of herpes simplex virus type 1 thymidine kinase suicide gene therapy in living subjects with positron emission tomography. Cancer Gene Ther 12(3): 329–339.
44. Yaghoubi, S. S., Berger, F., Gambhir, S. S. (2007). Studying the biodistribution of positron emission tomography reporter probes in mice. Nat Protoc 2(7): 1752–1755.
45. Yaghoubi, S. S., Gambhir, S. S. (2006). PET imaging of herpes simplex virus type 1 thymidine kinase (HSV1-tk) or mutant HSV1-sr39tk reporter gene expression in mice and humans using [18F]FHBG. Nat Protoc 1(6): 3069–3075.
46. Green, L. A., Nguyen, K., Berenji, B., Iyer, M., Bauer, E., Barrio, J. R. et al. (2004). A tracer kinetic model for 18FFHBG for quantitating herpes simplex virus type 1 thymidine kinase reporter gene expression in living animals using PET. J Nucl Med 45(9): 1560–1570.
47. Yaghoubi, S., Barrio, J. R., Dahlbom, M., Iyer, M., Namavari, M., Satyamurthy, N et al. (2001). Human pharmacokinetic and dosimetry studies of [(18)F]FHBG: a reporter probe for imaging herpes simplex virus type-1 thymidine kinase reporter gene expression. J Nucl Med 42(8): 1225–1234.
48. Yaghoubi, S. S., Couto, M. A., Chen, C. C., Polavaram, L., Cui, G., Sen, L. et al. (2006). Preclinical safety evaluation of 18F-FHBG: a PET reporter probe for imaging herpes simplex virus type 1 thymidine kinase (HSV1-tk) ormutant HSV1-sr39tk's expression. J Nucl Med 47(4): 706–715.
49. Min, J. J., Iyer, M., Gambhir, S. S. (2003). Comparison of [18F]FHBG and [14C]FIAU for imaging of HSV1-tk reporter gene expression: adenoviral infection vs stable transfection. Eur J Nucl Med Mol Imaging 30(11): 1547–1560.
50. Tjuvajev, J. G., Doubrovin, M., Akhurst, T., Cai, S., Balatoni, J., Alauddin, M. M. et al. (2002). Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. J Nucl Med 43(8): 1072–1083.
51. Kang, K. W., Min, J. J., Chen, X., Gambhir, S. S. (2005). Comparison of [14C]FMAU, [3H]FEAU, [14C]FIAU, and [3H]PCV for monitoring reporter gene expression of wild type and mutant herpes simplex virus type 1 thymidine kinase in cell culture. Mol Imaging Biol 7(4): 296–303.
52. Buursma, A. R., Rutgers, V., Hospers, G. A., Mulder, N. H., Vaalburg, W., de Vries, E. F. (2006). 18F-FEAU as a radiotracer for herpes simplex virus thymidine kinase gene expression: in-vitro comparison with other PET tracers. Nucl Med Commun 27(1): 25–30.
53. Williams, D. A., Baum, C. (2003).Medicine.Gene therapy–new challenges ahead. Science 302(5644): 400–401.
54. Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., Le Deist, F., Wulffraat, N., McIntyre, E. et al. (2003). A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348(3): 255–256.
55. Thomas, C. E., Ehrhardt, A., Kay, M. A. (2003). Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 4(5): 346–358.
56. Schellingerhout, D., Bogdanov, A., Jr., Marecos, E., Spear, M., Breakefield, X., Weissleder, R. (1998). Mapping the in vivo distribution of herpes simplex virions. HumGeneTher 9(11): 1543–1549.
57. Raty, J. K., Lesch, H. P., Wirth, T., Yla-Herttuala, S. (2008). Improving safety of gene therapy. Curr Drug Saf 3(1): 46–53.
58. Yaghoubi, S., Jensen, M. C., Satyamurthy, N., Budhiraja, S., Paik, D., Czernin, J. et al. (2008). Non-invasive detection of therapeutic cytolytic T cells with [18F]FHBG positron emission tomography in a glioma patient. Nature Clinical Practice Oncology 6(1): 53–58.
59. Adonai, N., Nguyen, K. N., Walsh, J., Iyer, M., Toyokuni, T., Phelps, M. E. et al. (2002). Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc Natl Acad Sci U S A 99(5): 3030–3035.
60. Tamura, M., Unno, K., Yonezawa, S., Hattori, K., Nakashima, E., Tsukada, H. et al. (2004). In vivo trafficking of endothelial progenitor cells their possible involvement in the tumor neovascularization. Life Sci 75(5): 575–584.
61. De, A., Lewis, X. Z., Gambhir, S. S. (2003). Noninvasive imaging of lentiviral-mediated reporter gene expression in living mice. Mol Ther 7(5 Pt 1): 681–691.